# Endometriosis and Brominated Flame Retardant (ENDOTOX Study)

> **NCT02651077** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 76 (actual)

## Conditions studied

- Endometriosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02651077
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2016-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02651077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02651077, "Endometriosis and Brominated Flame Retardant (ENDOTOX Study)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02651077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*